The standard of care has been to treat only the prostate surgery bed. The SPPORT study (RTOG/NRG Oncology 0534) was designed to see if adding short-term hormone therapy or short-term hormone therapy plus pelvic lymph node radiation significantly lowers recurrence and the risk of cancer spreading.